Grant: CIHR Fellowship
University of Toronto
$135,000.00
A novel placebo-based intervention for migraine: Randomised controlled trial
EF 2022-23
Résumé
INTRODUCTION. Migraine is a disorder involving frequent headaches affecting 10% of girls and 6% of boys. Placebos (empty pills) and migraine medications can both be similarly effective in reducing migraines by over 50%. We propose that an intervention aiming to maximise placebo effects may strongly reduce migraines.
We tested such an intervention in a previous pilot study of children with various disorders. The intervention involved an elaborate sham brain scanner - a "placebo machine" - that we told the children was inactive but could still help their brain heal itself through the power of suggestion. Ten of the 11 children showed improvements, including strong and lasting reductions in migraines. The proposed study further tests this placebo-based intervention.
METHODS. We will recruit 66 patients (aged 8 to 17) who will track their migraines for 30 days. Patients will then be randomly assigned into one of three groups. The full intervention group will undergo one placebo machine session, as in our previous study. The partial intervention group will undergo a similar procedure but will instead be told that the scanner is for measurement and not treatment; this will allow us to isolate the effect of positive expectations. The control group will receive no intervention. Participants will then track their migraines for another 30 days. In all groups, children and parents will be aware of the placebo nature of the intervention.
HYPOTHESES. We predict that the full intervention will reduce migraines more than the partial intervention and the control, the full intervention will be more effective than typical migraine medications, and the intervention will be most effective for younger participants and females.
CONCLUSION. This study could promote placebo-based interventions alongside existing treatments, helping patients reduce their medication intake and side effects.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
474000
Name
Olson Jeremy A
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Fellowships - Post-PhD
Projecttitle
A novel placebo-based intervention for migraine: Randomised controlled trial
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Headache; Migraine; Pain; Placebo; Suggestion
Abstract
INTRODUCTION. Migraine is a disorder involving frequent headaches affecting 10% of girls and 6% of boys. Placebos (empty pills) and migraine medications can both be similarly effective in reducing migraines by over 50%. We propose that an intervention aiming to maximise placebo effects may strongly reduce migraines.
We tested such an intervention in a previous pilot study of children with various disorders. The intervention involved an elaborate sham brain scanner - a "placebo machine" - that we told the children was inactive but could still help their brain heal itself through the power of suggestion. Ten of the 11 children showed improvements, including strong and lasting reductions in migraines. The proposed study further tests this placebo-based intervention.
METHODS. We will recruit 66 patients (aged 8 to 17) who will track their migraines for 30 days. Patients will then be randomly assigned into one of three groups. The full intervention group will undergo one placebo machine session, as in our previous study. The partial intervention group will undergo a similar procedure but will instead be told that the scanner is for measurement and not treatment; this will allow us to isolate the effect of positive expectations. The control group will receive no intervention. Participants will then track their migraines for another 30 days. In all groups, children and parents will be aware of the placebo nature of the intervention.
HYPOTHESES. We predict that the full intervention will reduce migraines more than the partial intervention and the control, the full intervention will be more effective than typical migraine medications, and the intervention will be most effective for younger participants and females.
CONCLUSION. This study could promote placebo-based interventions alongside existing treatments, helping patients reduce their medication intake and side effects.
Competitiondate
202210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Olson, Jeremy A
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~